Treatment with ranitidine of ischemic brain edema

Eur J Pharmacol. 1994 Nov 3;264(3):455-8. doi: 10.1016/0014-2999(94)00546-x.

Abstract

Cerebral ischemia was produced by bilateral common carotid artery occlusion in female Sprague-Dawley rats. Ranitidine, a histamine H2 receptor blocking agent, given intraperitoneally 30 min prior to ischemia, exerted a dose-dependent protective effect on water accumulation and ion shifts in the brain (Na+, K+ and Ca2+). To decide whether ranitidine can prevent ischemia-induced brain edema when given in the postischemic period, ranitidine (10 mg/kg i.p.) was administered 1, 2, and 3 h respectively after the onset of cerebral ischemia. Early (1 h) postocclusion treatment was still able to attenuate the ischemia-induced water accumulation and maldistribution of ions in the brain tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Brain Chemistry / drug effects
  • Brain Edema / etiology
  • Brain Edema / prevention & control*
  • Brain Ischemia / complications
  • Brain Ischemia / drug therapy*
  • Calcium / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Injections, Intraperitoneal
  • Potassium / metabolism
  • Ranitidine / administration & dosage
  • Ranitidine / pharmacology
  • Ranitidine / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Sodium / metabolism
  • Water / metabolism

Substances

  • Water
  • Ranitidine
  • Sodium
  • Potassium
  • Calcium